Method for increasing the specific production rate of eukaryotic cells

What is this patent about?

’983 is related to the field of large-scale biopharmaceutical manufacturing, specifically the optimization of eukaryotic cell culture processes. In the production of therapeutic proteins like monoclonal antibodies, manufacturers often struggle to maximize the amount of protein produced per cell—known as specific productivity—without triggering cell death or compromising the structural integrity of the final drug product.

The underlying idea behind ’983 is that the non-proteinogenic amino acid meta-tyrosine can be used as a metabolic rheostat to decouple cell growth from protein production. While traditional methods rely on harsh environmental shifts in temperature or pH to boost productivity, this invention utilizes a specific concentration of meta-tyrosine to naturally slow biomass accumulation while simultaneously forcing the remaining cellular machinery to increase its per-cell output of the target polypeptide.

The claims of ’983 focus on a method for increasing the specific productivity (qP) of a recombinant CHO cell by at least 5% through the addition of meta-tyrosine to the culture medium. The independent claim specifically protects the use of this additive at a concentration range between 0.2 mM and 0.7 mM, targeting the production of exogenous polypeptides in Chinese Hamster Ovary cell lines.

In practice, the invention works by supplementing a chemically defined, protein-free medium with meta-tyrosine, which results in a lower viable cell density but maintains a high overall product titer. To prevent the cell from accidentally incorporating meta-tyrosine into the protein sequence in place of phenylalanine—a phenomenon known as translational misincorporation—the process maintains a specific molar ratio of meta-tyrosine to phenylalanine, ensuring high sequence fidelity and product purity.

This approach differs from prior solutions by avoiding the use of cytotoxic drugs like valproic acid or sodium butyrate, which often induce apoptosis and complicate downstream purification. Unlike physicochemical shifts in temperature or osmolality that are difficult to scale uniformly in large bioreactors, the use of a media additive provides a more predictable and easily controlled mechanism for enhancing yield without sacrificing cell viability.